Author Archives: admin


Irreversible No Longer: Blind Mice See Again Thanks To New Method of Synthesizing Lost Cells – Good News Network

Reprinted with permission fromWorld At Large, a news website which covers politics, nature, science, health, and travel.

Age-related macular degeneration (MD) is a variety of ocular disease that affects so many millions of people, its downright characterized as nothing more than the process of aging.

In fact, the study of MD has proven itself to be so fruitful for understanding aging as a whole, MD has become one of the first places that scientists have looked to in order to attempt to repair the damage of aging and restoring youthful, or normal function.

Now in a new paper published in Nature, researchers demonstrate an alternative to stem cells by creating replacement photoreceptors from skin fibroblast cells via pharmacological-conversiona process that promises to be cheaper, faster, and unburdened by ethical and legal restrictions.

Containing the genetic code for every protein we need to build and repair our cells, DNA can become damaged over time through the stresses of life. Similarly to how scratches or cracks in a CD prevent lasers from reading the information on the disk, damaged DNA becomes difficult, and even impossible for our RNA (which you could imagine as the laser inside the CD player) to read the genetic information contained therein.

WATCH: Blind Man Develops Smart Cane That Uses Google Maps and Sensors to Identify Ones Surroundings

The photoreceptor is the neuron in the eye that turns on visual circuity in response to light which enables us to have vision, says Sai Chavala, Ph.D. and author of the new paper.

The loss of photoreceptors can result in MD and other retinal diseases that lead to irreversible blindness. In this new study, however, cells called fibroblasts can be chemically reprogrammed to produce photoreceptor-like cells that are now shown to restore vision in mice.

Fibroblasts are cells that help maintain the structural integrity of connective tissues, and a reduction in fibroblast cell count leads to wrinkled skin.

Sai Chavala and colleagues from the Center for Retina Innovation in Dallas, Texas, found a set of five compounds that can drive embryonic fibroblast cells to convert themselves into retinal, rod-like, photoreceptors in both mice and human cells.

Stem cell-based strategies are extremely exciting, Dr. Chavala tells World at Large, but adds that generating these cells can be cumbersome and time-consuming. Describing his strategy of chemically reprogramming existing cells as a breakthrough, Chavala added that the generation of the photoreceptors using his method requires a fraction of the time.

In the study, these converted photoreceptors were transplanted into the eyes of 14 blind mice to see if they would restore vision.

CHECK OUT: LEGO Unveils New Bricks That Will Help Teach Blind Children to Read Braille

Owing to their nature, mice with working vision prefer dark spaces, and so a test of whether or not the transplant was a success was fairly straight forward; create a bright space and a dark space and wait to see which one was preferred by the mice.

Six mice were found to not only have restored visual function and reflexesnotably in the pupilbut they also preferred to spend their time in the dark space. Chavala hypothesizes that it could have been down to how many of the chemically-reprogrammed cells survived the transplant into the retina that determined whether vision was restored in the mice or not.

What makes interventions like thesewhich involve creating brand new cells to replace the damaged onesso effective and exciting in the field of aging is that they present an alternative to natural replication by bypassing the difficulties that our own cells have with trying to repair themselves from DNA that features double-strand breaks or other blemishes.

Adding that these conversions of fibroblasts to photoreceptors has also been done in humans, Chavala detailed why he believes the treatments and future research to spring from this discovery are going to change the field of ophthalmology.

CHECK OUT: In World First Blind People Have Their Vision Restored Thanks to Stem Cells From Deceased Organ Donors

We [] believe this can be a game changer in the field of regenerative ophthalmology. We also believe this is a platform technology and have already started establishing protocols to generate retinal ganglion cells valuable for patients suffering from glaucoma, says Chavala.

In addition to bypassing the ethical and political restrictions and hiccups with using embryonic human stem cells, the process takes two weeks, costs less, and is more scalable than using stem cells.

WATCH: Hundreds of People Are Being Cured of Blindness Every Day With Cheap, Minutes-Long Surgery

It is intriguing to postulate that the addition of other molecules or modifications to the culture conditions can yield other types of neurons beneficial for a variety of neurological diseases, he adds, discussing possible alternatives to photoreceptor generation from fibroblasts.

Finally, Chavala is rapidly approaching human trials and hopes to have an FDA-approved treatment out the other end of the pipeline in 2-3 years, saying he is thrilled with the possibility of allowing millions of people to regain their lost vision.

Its Not Hard To See That You Should Share This Good News With Your Friends On Social Media

Read more:
Irreversible No Longer: Blind Mice See Again Thanks To New Method of Synthesizing Lost Cells - Good News Network

Global High Throughput Screening (HTS) Industry | National – Baker City Herald

NEW YORK, April 20, 2020 /PRNewswire/ --High Throughput Screening (HTS) market worldwide is projected to grow by US$8.8 Billion, driven by a compounded growth of 7.5%. Consumables/Reagents, one of the segments analyzed and sized in this study, displays the potential to grow at over 8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$13.2 Billion by the year 2025, Consumables/Reagents will bring in healthy gains adding significant momentum to global growth.

Read the full report: https://www.reportlinker.com/p04368329/?utm_source=PRN

- Representing the developed world, the United States will maintain a 6.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$306.6 Million to the region's size and clout in the next 5 to 6 years. Over US$260.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Consumables/Reagents will reach a market size of US$658.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.1% over the next couple of years and add approximately US$2.5 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p04368329/?utm_source=PRN

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

High Throughput Screening (HTS): A PreludeRecent Market ActivityHTS: The Mainstream Technology for Drug Discovery ProgramsUnparalleled Advantages in Compound Screening Drives WiderAdoptionKey Benefits of HTS - An OverviewSoaring R&D Spending Creates Conducive Environment for HTSShift towards High Throughput Research Builds Momentum for HTSUpward Trajectory in Med Tech Sector Generates ParallelOpportunitiesStable Economic Outlook to Keep Market Sentiment Intact in theNear TermDeveloped Regions: Key Revenue ContributorsHTS Adoption Continues to Expand in Developing RegionsKey Factors Driving Demand for HTS in the Developing RegionsCompetitive ScenarioLeading Players in the World HTS MarketM&A ActivityGlobal Competitor Market SharesHigh Throughput Screening (HTS) Competitor Market ShareScenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

Agilent Technologies, Inc. (USA)Aurora Biomed, Inc. (Canada)Axxam SpA (Italy)BD Biosciences (USA)Danaher Corporation (USA)Beckman Coulter, Inc. (USA)Molecular Devices Inc. (USA)Pall ForteBio LLC (USA)Bio-Rad Laboratories, Inc. (USA)BioTek Instruments Inc. (USA)BMG LABTECH GmbH (Germany)Charles River Laboratories International, Inc. (USA)Corning Inc. (USA)DiscoveRx Corporation (USA)Evotec AG (Germany)F. Hoffmann-La Roche Ltd. (Switzerland)Genedata AG (Switzerland)IntelliCyt Corporation (USA)Luminex Corporation (USA)PerkinElmer, Inc. (USA)Sigma-Aldrich Corp. (USA)Tecan Group Ltd. (Switzerland)Thermo Fisher Scientific Inc. (USA)

3. MARKET TRENDS & DRIVERS

Cell-based Assay: The Widely Used HTS TechnologyResolving Technical Limitations: Cornerstone for Future Successof Cell-based HTSHTS Aims to Expand Use Case in Biochemical ApplicationsLabel-Free HTS Demonstrates Fastest GrowthLab-on-a-Chip HTS Seeks to Proliferate the MarketBioinformatics HTS Enhanced with Computational AlgorithmsPositive Prognosis across End-Use Markets to Underpin RevenueGrowthPharmaceutical Industry Leads the WayHTS Deployments Soar in AcademiaProgressive Advancements in HTS Instruments Accelerate MarketGrowthMicroplate Handling Systems: An Important HTS Instrument TypeLiquid Handling Devices: A Necessity in HTS ProcessesMicroscopic Systems Facilitate Seamless Quantitative AnalysisAdvanced Software Platforms Augment HTS ProficiencyServices: An Important Revenue Generating SegmentExpansion in Compound Libraries Widens Functional Scope of HTSCompound Libraries Facilitate Simultaneous Functional Genomics& Small Molecule AnalysisLaboratory Automation & Miniaturization Spell Opportunities forHTSMiniaturization of Compound Screening Processes Drives Demandfor HTSHTS Miniaturization - Technology DevelopmentsHTS Robotics Support MiniaturizationIVC - A Miniaturized, Powerful HTS TechnologyHTS Assumes Critical Importance in Target Identification &ValidationHTS Gathers Steam in Primary Screening ApplicationsHTS Perceives Bright Future in Stem Cell ResearchHTS in Kinase Inhibitors IdentificationHTS in Alzheimer's Disease Drug DiscoveryHTS for Less Simplified PCR SystemsHTFC Eases Metabolic Activity Analysis for Pharmaceutical DrugsOpen Access Platforms Widen HTS Audience BaseNeed for Stringent QA System to Keep Failures at BayHigh Throughput Screening (HTS) Vs. High Content Screening (HCS)Rise in Adoption of HCS Technology in HTS Laboratories

4. GLOBAL MARKET PERSPECTIVE

Table 1: High Throughput Screening (HTS) Global MarketEstimates and Forecasts in US$ Million by Region/Country:2018-2025Table 2: High Throughput Screening (HTS) Global RetrospectiveMarket Scenario in US$ Million by Region/Country: 2009-2017Table 3: High Throughput Screening (HTS) Market Share Shiftacross Key Geographies Worldwide: 2009 VS 2019 VS 2025Table 4: Consumables/Reagents (Product Type) World Market byRegion/Country in US$ Million: 2018 to 2025Table 5: Consumables/Reagents (Product Type) Historic MarketAnalysis by Region/Country in US$ Million: 2009 to 2017Table 6: Consumables/Reagents (Product Type) Market ShareBreakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS2025Table 7: Instruments (Product Type) Potential Growth MarketsWorldwide in US$ Million: 2018 to 2025Table 8: Instruments (Product Type) Historic Market Perspectiveby Region/Country in US$ Million: 2009 to 2017Table 9: Instruments (Product Type) Market Sales Breakdown byRegion/Country in Percentage: 2009 VS 2019 VS 2025Table 10: Software & Services (Product Type) Geographic MarketSpread Worldwide in US$ Million: 2018 to 2025Table 11: Software & Services (Product Type) Region WiseBreakdown of Global Historic Demand in US$ Million: 2009 to2017Table 12: Software & Services (Product Type) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 13: Cell-based Assay (Technology) World Market Estimatesand Forecasts by Region/Country in US$ Million: 2018 to 2025Table 14: Cell-based Assay (Technology) Market Historic Reviewby Region/Country in US$ Million: 2009 to 2017Table 15: Cell-based Assay (Technology) Market Share Breakdownby Region/Country: 2009 VS 2019 VS 2025Table 16: Label-Free Technology (Technology) World Market byRegion/Country in US$ Million: 2018 to 2025Table 17: Label-Free Technology (Technology) Historic MarketAnalysis by Region/Country in US$ Million: 2009 to 2017Table 18: Label-Free Technology (Technology) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 19: Other Technologies (Technology) World MarketEstimates and Forecasts in US$ Million by Region/Country: 2018to 2025Table 20: Other Technologies (Technology) Market WorldwideHistoric Review by Region/Country in US$ Million: 2009 to 2017Table 21: Other Technologies (Technology) Market PercentageShare Distribution by Region/Country: 2009 VS 2019 VS 2025Table 22: Target Identification & Validation (Application)Global Opportunity Assessment in US$ Million by Region/Country:2018-2025Table 23: Target Identification & Validation (Application)Historic Sales Analysis in US$ Million by Region/Country:2009-2017Table 24: Target Identification & Validation (Application)Percentage Share Breakdown of Global Sales by Region/Country:2009 VS 2019 VS 2025Table 25: Primary & Secondary Screening (Application) WorldwideSales in US$ Million by Region/Country: 2018-2025Table 26: Primary & Secondary Screening (Application) HistoricDemand Patterns in US$ Million by Region/Country: 2009-2017Table 27: Primary & Secondary Screening (Application) MarketShare Shift across Key Geographies: 2009 VS 2019 VS 2025Table 28: Toxicology Assessment (Application) Global MarketEstimates & Forecasts in US$ Million by Region/Country:2018-2025Table 29: Toxicology Assessment (Application) RetrospectiveDemand Analysis in US$ Million by Region/Country: 2009-2017Table 30: Toxicology Assessment (Application) Market ShareBreakdown by Region/Country: 2009 VS 2019 VS 2025Table 31: Other Applications (Application) Demand PotentialWorldwide in US$ Million by Region/Country: 2018-2025Table 32: Other Applications (Application) Historic SalesAnalysis in US$ Million by Region/Country: 2009-2017Table 33: Other Applications (Application) Share BreakdownReview by Region/Country: 2009 VS 2019 VS 2025Table 34: Pharmaceutical & Biotechnology Companies (End-Use)Worldwide Latent Demand Forecasts in US$ Million byRegion/Country: 2018-2025Table 35: Pharmaceutical & Biotechnology Companies (End-Use)Global Historic Analysis in US$ Million by Region/Country:2009-2017Table 36: Pharmaceutical & Biotechnology Companies (End-Use)Distribution of Global Sales by Region/Country: 2009 VS 2019 VS2025Table 37: Academic & Government Institutes (End-Use) SalesEstimates and Forecasts in US$ Million by Region/Country forthe Years 2018 through 2025Table 38: Academic & Government Institutes (End-Use) Analysisof Historic Sales in US$ Million by Region/Country for theYears 2009 to 2017Table 39: Academic & Government Institutes (End-Use) GlobalMarket Share Distribution by Region/Country for 2009, 2019, and2025Table 40: Contract Research Organizations (CRO) (End-Use)Global Opportunity Assessment in US$ Million by Region/Country:2018-2025Table 41: Contract Research Organizations (CRO) (End-Use)Historic Sales Analysis in US$ Million by Region/Country:2009-2017Table 42: Contract Research Organizations (CRO) (End-Use)Percentage Share Breakdown of Global Sales by Region/Country:2009 VS 2019 VS 2025Table 43: Other End-Uses (End-Use) Worldwide Sales in US$Million by Region/Country: 2018-2025Table 44: Other End-Uses (End-Use) Historic Demand Patterns inUS$ Million by Region/Country: 2009-2017Table 45: Other End-Uses (End-Use) Market Share Shift acrossKey Geographies: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSISUNITED STATESMarket Facts & FiguresUS High Throughput Screening (HTS) Market Share (in %) byCompany: 2020 & 2025Market AnalyticsTable 46: United States High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Product Type: 2018to 2025Table 47: High Throughput Screening (HTS) Market in the UnitedStates by Product Type: A Historic Review in US$ Million for2009-2017Table 48: United States High Throughput Screening (HTS) MarketShare Breakdown by Product Type: 2009 VS 2019 VS 2025Table 49: High Throughput Screening (HTS) Market in US$ Millionin the United States by Technology: 2018-2025Table 50: United States High Throughput Screening (HTS) MarketRetrospective Analysis in US$ Million by Technology: 2009-2017Table 51: United States High Throughput Screening (HTS) MarketShare Breakdown by Technology: 2009 VS 2019 VS 2025Table 52: United States High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by Application: 2018 to 2025Table 53: High Throughput Screening (HTS) Historic DemandPatterns in the United States by Application in US$ Million for2009-2017Table 54: High Throughput Screening (HTS) Market ShareBreakdown in the United States by Application: 2009 VS 2019 VS2025Table 55: United States High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by End-Use: 2018 to 2025Table 56: High Throughput Screening (HTS) Historic DemandPatterns in the United States by End-Use in US$ Million for2009-2017Table 57: High Throughput Screening (HTS) Market ShareBreakdown in the United States by End-Use: 2009 VS 2019 VS 2025CANADATable 58: Canadian High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type: 2018 to2025Table 59: Canadian High Throughput Screening (HTS) HistoricMarket Review by Product Type in US$ Million: 2009-2017Table 60: High Throughput Screening (HTS) Market in Canada:Percentage Share Breakdown of Sales by Product Type for 2009,2019, and 2025Table 61: High Throughput Screening (HTS) Market Analysis inCanada in US$ Million by Technology: 2018-2025Table 62: High Throughput Screening (HTS) Market in Canada:Historic Review in US$ Million by Technology for the Period2009-2017Table 63: Canadian High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 64: Canadian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 65: High Throughput Screening (HTS) Market in Canada:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 66: Canadian High Throughput Screening (HTS) Market ShareAnalysis by Application: 2009 VS 2019 VS 2025Table 67: Canadian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by End-Use: 2018 to2025Table 68: High Throughput Screening (HTS) Market in Canada:Summarization of Historic Demand Patterns in US$ Million byEnd-Use for 2009-2017Table 69: Canadian High Throughput Screening (HTS) Market ShareAnalysis by End-Use: 2009 VS 2019 VS 2025JAPANTable 70: Japanese Market for High Throughput Screening (HTS):Annual Sales Estimates and Projections in US$ Million byProduct Type for the Period 2018-2025Table 71: High Throughput Screening (HTS) Market in Japan:Historic Sales Analysis in US$ Million by Product Type for thePeriod 2009-2017Table 72: Japanese High Throughput Screening (HTS) Market ShareAnalysis by Product Type: 2009 VS 2019 VS 2025Table 73: Japanese Medium & Long-Term Outlook for HighThroughput Screening (HTS) Market in US$ Million by Technology:2018-2025Table 74: High Throughput Screening (HTS) Market in Japan inUS$ Million by Technology: 2009-2017Table 75: Japanese High Throughput Screening (HTS) MarketPercentage Share Distribution by Technology: 2009 VS 2019 VS2025Table 76: Japanese Demand Estimates and Forecasts for HighThroughput Screening (HTS) in US$ Million by Application: 2018to 2025Table 77: Japanese High Throughput Screening (HTS) Market inUS$ Million by Application: 2009-2017Table 78: High Throughput Screening (HTS) Market Share Shift inJapan by Application: 2009 VS 2019 VS 2025Table 79: Japanese Demand Estimates and Forecasts for HighThroughput Screening (HTS) in US$ Million by End-Use: 2018 to2025Table 80: Japanese High Throughput Screening (HTS) Market inUS$ Million by End-Use: 2009-2017Table 81: High Throughput Screening (HTS) Market Share Shift inJapan by End-Use: 2009 VS 2019 VS 2025CHINATable 82: Chinese High Throughput Screening (HTS) Market GrowthProspects in US$ Million by Product Type for the Period2018-2025Table 83: High Throughput Screening (HTS) Historic MarketAnalysis in China in US$ Million by Product Type: 2009-2017Table 84: Chinese High Throughput Screening (HTS) Market byProduct Type: Percentage Breakdown of Sales for 2009, 2019, and2025Table 85: High Throughput Screening (HTS) Market Estimates andForecasts in China in US$ Million by Technology: 2018-2025Table 86: Chinese High Throughput Screening (HTS) RetrospectiveMarket Scenario in US$ Million by Technology: 2009-2017Table 87: High Throughput Screening (HTS) Market in China:Percentage Share Analysis by Technology for 2009, 2019, and2025Table 88: Chinese Demand for High Throughput Screening (HTS) inUS$ Million by Application: 2018 to 2025Table 89: High Throughput Screening (HTS) Market Review inChina in US$ Million by Application: 2009-2017Table 90: Chinese High Throughput Screening (HTS) Market ShareBreakdown by Application: 2009 VS 2019 VS 2025Table 91: Chinese Demand for High Throughput Screening (HTS) inUS$ Million by End-Use: 2018 to 2025Table 92: High Throughput Screening (HTS) Market Review inChina in US$ Million by End-Use: 2009-2017Table 93: Chinese High Throughput Screening (HTS) Market ShareBreakdown by End-Use: 2009 VS 2019 VS 2025EUROPESMarket Facts & FiguresEuropean High Throughput Screening (HTS) Market: CompetitorMarket Share Scenario (in %) for 2020 & 2025Market AnalyticsTable 94: European High Throughput Screening (HTS) MarketDemand Scenario in US$ Million by Region/Country: 2018-2025Table 95: High Throughput Screening (HTS) Market in Europe:A Historic Market Perspective in US$ Million by Region/Countryfor the Period 2009-2017Table 96: European High Throughput Screening (HTS) Market ShareShift by Region/Country: 2009 VS 2019 VS 2025Table 97: European High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type:2018-2025Table 98: High Throughput Screening (HTS) Market in Europe inUS$ Million by Product Type: A Historic Review for the Period2009-2017Table 99: European High Throughput Screening (HTS) Market ShareBreakdown by Product Type: 2009 VS 2019 VS 2025Table 100: European High Throughput Screening (HTS) MarketAssessment in US$ Million by Technology: 2018-2025Table 101: European High Throughput Screening (HTS) HistoricMarket Review in US$ Million by Technology: 2009-2017Table 102: High Throughput Screening (HTS) Market in Europe:Percentage Breakdown of Sales by Technology for 2009, 2019, and2025Table 103: European High Throughput Screening (HTS) AddressableMarket Opportunity in US$ Million by Application: 2018-2025Table 104: High Throughput Screening (HTS) Market in Europe:Summarization of Historic Demand in US$ Million by Applicationfor the Period 2009-2017Table 105: European High Throughput Screening (HTS) MarketShare Analysis by Application: 2009 VS 2019 VS 2025Table 106: European High Throughput Screening (HTS) AddressableMarket Opportunity in US$ Million by End-Use: 2018-2025Table 107: High Throughput Screening (HTS) Market in Europe:Summarization of Historic Demand in US$ Million by End-Use forthe Period 2009-2017Table 108: European High Throughput Screening (HTS) MarketShare Analysis by End-Use: 2009 VS 2019 VS 2025FRANCETable 109: High Throughput Screening (HTS) Market in France byProduct Type: Estimates and Projections in US$ Million for thePeriod 2018-2025Table 110: French High Throughput Screening (HTS) HistoricMarket Scenario in US$ Million by Product Type: 2009-2017Table 111: French High Throughput Screening (HTS) Market ShareAnalysis by Product Type: 2009 VS 2019 VS 2025Table 112: French High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Technology:2018-2025Table 113: French High Throughput Screening (HTS) HistoricMarket Analysis in US$ Million by Technology: 2009-2017Table 114: French High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 115: High Throughput Screening (HTS) Quantitative DemandAnalysis in France in US$ Million by Application: 2018-2025Table 116: French High Throughput Screening (HTS) HistoricMarket Review in US$ Million by Application: 2009-2017Table 117: French High Throughput Screening (HTS) Market ShareAnalysis: A 17-Year Perspective by Application for 2009, 2019,and 2025Table 118: High Throughput Screening (HTS) Quantitative DemandAnalysis in France in US$ Million by End-Use: 2018-2025Table 119: French High Throughput Screening (HTS) HistoricMarket Review in US$ Million by End-Use: 2009-2017Table 120: French High Throughput Screening (HTS) Market ShareAnalysis: A 17-Year Perspective by End-Use for 2009, 2019, and2025GERMANYTable 121: High Throughput Screening (HTS) Market in Germany:Recent Past, Current and Future Analysis in US$ Million byProduct Type for the Period 2018-2025Table 122: German High Throughput Screening (HTS) HistoricMarket Analysis in US$ Million by Product Type: 2009-2017Table 123: German High Throughput Screening (HTS) Market ShareBreakdown by Product Type: 2009 VS 2019 VS 2025Table 124: German High Throughput Screening (HTS) Latent DemandForecasts in US$ Million by Technology: 2018-2025Table 125: High Throughput Screening (HTS) Market in Germany:A Historic Perspective by Technology in US$ Million for thePeriod 2009-2017Table 126: German High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 127: High Throughput Screening (HTS) Market in Germany:Annual Sales Estimates and Forecasts in US$ Million byApplication for the Period 2018-2025Table 128: German High Throughput Screening (HTS) Market inRetrospect in US$ Million by Application: 2009-2017Table 129: High Throughput Screening (HTS) Market ShareDistribution in Germany by Application: 2009 VS 2019 VS 2025Table 130: High Throughput Screening (HTS) Market in Germany:Annual Sales Estimates and Forecasts in US$ Million by End-Usefor the Period 2018-2025Table 131: German High Throughput Screening (HTS) Market inRetrospect in US$ Million by End-Use: 2009-2017Table 132: High Throughput Screening (HTS) Market ShareDistribution in Germany by End-Use: 2009 VS 2019 VS 2025ITALYTable 133: Italian High Throughput Screening (HTS) MarketGrowth Prospects in US$ Million by Product Type for the Period2018-2025Table 134: High Throughput Screening (HTS) Historic MarketAnalysis in Italy in US$ Million by Product Type: 2009-2017Table 135: Italian High Throughput Screening (HTS) Market byProduct Type: Percentage Breakdown of Sales for 2009, 2019, and2025Table 136: High Throughput Screening (HTS) Market Estimates andForecasts in Italy in US$ Million by Technology: 2018-2025Table 137: Italian High Throughput Screening (HTS)Retrospective Market Scenario in US$ Million by Technology:2009-2017Table 138: High Throughput Screening (HTS) Market in Italy:Percentage Share Analysis by Technology for 2009, 2019, and2025Table 139: Italian Demand for High Throughput Screening (HTS)in US$ Million by Application: 2018 to 2025Table 140: High Throughput Screening (HTS) Market Review inItaly in US$ Million by Application: 2009-2017Table 141: Italian High Throughput Screening (HTS) Market ShareBreakdown by Application: 2009 VS 2019 VS 2025Table 142: Italian Demand for High Throughput Screening (HTS)in US$ Million by End-Use: 2018 to 2025Table 143: High Throughput Screening (HTS) Market Review inItaly in US$ Million by End-Use: 2009-2017Table 144: Italian High Throughput Screening (HTS) Market ShareBreakdown by End-Use: 2009 VS 2019 VS 2025UNITED KINGDOMTable 145: United Kingdom Market for High Throughput Screening(HTS): Annual Sales Estimates and Projections in US$ Million byProduct Type for the Period 2018-2025Table 146: High Throughput Screening (HTS) Market in the UnitedKingdom: Historic Sales Analysis in US$ Million by Product Typefor the Period 2009-2017Table 147: United Kingdom High Throughput Screening (HTS)Market Share Analysis by Product Type: 2009 VS 2019 VS 2025Table 148: United Kingdom Medium & Long-Term Outlook for HighThroughput Screening (HTS) Market in US$ Million by Technology:2018-2025Table 149: High Throughput Screening (HTS) Market in the UnitedKingdom in US$ Million by Technology: 2009-2017Table 150: United Kingdom High Throughput Screening (HTS)Market Percentage Share Distribution by Technology: 2009 VS2019 VS 2025Table 151: United Kingdom Demand Estimates and Forecasts forHigh Throughput Screening (HTS) in US$ Million by Application:2018 to 2025Table 152: United Kingdom High Throughput Screening (HTS)Market in US$ Million by Application: 2009-2017Table 153: High Throughput Screening (HTS) Market Share Shiftin the United Kingdom by Application: 2009 VS 2019 VS 2025Table 154: United Kingdom Demand Estimates and Forecasts forHigh Throughput Screening (HTS) in US$ Million by End-Use: 2018to 2025Table 155: United Kingdom High Throughput Screening (HTS)Market in US$ Million by End-Use: 2009-2017Table 156: High Throughput Screening (HTS) Market Share Shiftin the United Kingdom by End-Use: 2009 VS 2019 VS 2025SPAINTable 157: Spanish High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type: 2018 to2025Table 158: Spanish High Throughput Screening (HTS) HistoricMarket Review by Product Type in US$ Million: 2009-2017Table 159: High Throughput Screening (HTS) Market in Spain:Percentage Share Breakdown of Sales by Product Type for 2009,2019, and 2025Table 160: High Throughput Screening (HTS) Market Analysis inSpain in US$ Million by Technology: 2018-2025Table 161: High Throughput Screening (HTS) Market in Spain:Historic Review in US$ Million by Technology for the Period2009-2017Table 162: Spanish High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 163: Spanish High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 164: High Throughput Screening (HTS) Market in Spain:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 165: Spanish High Throughput Screening (HTS) Market ShareAnalysis by Application: 2009 VS 2019 VS 2025Table 166: Spanish High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by End-Use: 2018 to2025Table 167: High Throughput Screening (HTS) Market in Spain:Summarization of Historic Demand Patterns in US$ Million byEnd-Use for 2009-2017Table 168: Spanish High Throughput Screening (HTS) Market ShareAnalysis by End-Use: 2009 VS 2019 VS 2025RUSSIATable 169: Russian High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Product Type: 2018to 2025Table 170: High Throughput Screening (HTS) Market in Russia byProduct Type: A Historic Review in US$ Million for 2009-2017Table 171: Russian High Throughput Screening (HTS) Market ShareBreakdown by Product Type: 2009 VS 2019 VS 2025Table 172: High Throughput Screening (HTS) Market in US$Million in Russia by Technology: 2018-2025Table 173: Russian High Throughput Screening (HTS) MarketRetrospective Analysis in US$ Million by Technology: 2009-2017Table 174: Russian High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 175: Russian High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by Application: 2018 to 2025Table 176: High Throughput Screening (HTS) Historic DemandPatterns in Russia by Application in US$ Million for 2009-2017Table 177: High Throughput Screening (HTS) Market ShareBreakdown in Russia by Application: 2009 VS 2019 VS 2025Table 178: Russian High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by End-Use: 2018 to 2025Table 179: High Throughput Screening (HTS) Historic DemandPatterns in Russia by End-Use in US$ Million for 2009-2017Table 180: High Throughput Screening (HTS) Market ShareBreakdown in Russia by End-Use: 2009 VS 2019 VS 2025REST OF EUROPETable 181: Rest of Europe High Throughput Screening (HTS)Market Estimates and Forecasts in US$ Million by Product Type:2018-2025Table 182: High Throughput Screening (HTS) Market in Rest ofEurope in US$ Million by Product Type: A Historic Review forthe Period 2009-2017Table 183: Rest of Europe High Throughput Screening (HTS)Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025Table 184: Rest of Europe High Throughput Screening (HTS)Market Assessment in US$ Million by Technology: 2018-2025Table 185: Rest of Europe High Throughput Screening (HTS)Historic Market Review in US$ Million by Technology: 2009-2017Table 186: High Throughput Screening (HTS) Market in Rest ofEurope: Percentage Breakdown of Sales by Technology for 2009,2019, and 2025Table 187: Rest of Europe High Throughput Screening (HTS)Addressable Market Opportunity in US$ Million by Application:2018-2025Table 188: High Throughput Screening (HTS) Market in Rest ofEurope: Summarization of Historic Demand in US$ Million byApplication for the Period 2009-2017Table 189: Rest of Europe High Throughput Screening (HTS)Market Share Analysis by Application: 2009 VS 2019 VS 2025Table 190: Rest of Europe High Throughput Screening (HTS)Addressable Market Opportunity in US$ Million by End-Use:2018-2025Table 191: High Throughput Screening (HTS) Market in Rest ofEurope: Summarization of Historic Demand in US$ Million byEnd-Use for the Period 2009-2017Table 192: Rest of Europe High Throughput Screening (HTS)Market Share Analysis by End-Use: 2009 VS 2019 VS 2025ASIA-PACIFICTable 193: Asia-Pacific High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Region/Country:2018-2025Table 194: High Throughput Screening (HTS) Market inAsia-Pacific: Historic Market Analysis in US$ Million byRegion/Country for the Period 2009-2017Table 195: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis by Region/Country: 2009 VS 2019 VS 2025Table 196: High Throughput Screening (HTS) Market inAsia-Pacific by Product Type: Estimates and Projections in US$Million for the Period 2018-2025Table 197: Asia-Pacific High Throughput Screening (HTS)Historic Market Scenario in US$ Million by Product Type:2009-2017Table 198: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis by Product Type: 2009 VS 2019 VS 2025Table 199: Asia-Pacific High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Technology:2018-2025Table 200: Asia-Pacific High Throughput Screening (HTS)Historic Market Analysis in US$ Million by Technology:2009-2017Table 201: Asia-Pacific High Throughput Screening (HTS)Historic Market Analysis in US$ Million by Technology: 2009 VS2019 VS 2025Table 202: High Throughput Screening (HTS) Quantitative DemandAnalysis in Asia-Pacific in US$ Million by Application:2018-2025Table 203: Asia-Pacific High Throughput Screening (HTS)Historic Market Review in US$ Million by Application: 2009-2017Table 204: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis: A 17-Year Perspective by Application for 2009,2019, and 2025Table 205: High Throughput Screening (HTS) Quantitative DemandAnalysis in Asia-Pacific in US$ Million by End-Use: 2018-2025Table 206: Asia-Pacific High Throughput Screening (HTS)Historic Market Review in US$ Million by End-Use: 2009-2017Table 207: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis: A 17-Year Perspective by End-Use for 2009,2019, and 2025AUSTRALIATable 208: High Throughput Screening (HTS) Market in Australia:Recent Past, Current and Future Analysis in US$ Million byProduct Type for the Period 2018-2025Table 209: Australian High Throughput Screening (HTS) HistoricMarket Analysis in US$ Million by Product Type: 2009-2017Table 210: Australian High Throughput Screening (HTS) MarketShare Breakdown by Product Type: 2009 VS 2019 VS 2025Table 211: Australian High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by Technology: 2018-2025Table 212: High Throughput Screening (HTS) Market in Australia:A Historic Perspective by Technology in US$ Million for thePeriod 2009-2017Table 213: Australian High Throughput Screening (HTS) MarketShare Breakdown by Technology: 2009 VS 2019 VS 2025Table 214: High Throughput Screening (HTS) Market in Australia:Annual Sales Estimates and Forecasts in US$ Million byApplication for the Period 2018-2025Table 215: Australian High Throughput Screening (HTS) Market inRetrospect in US$ Million by Application: 2009-2017Table 216: High Throughput Screening (HTS) Market ShareDistribution in Australia by Application: 2009 VS 2019 VS 2025Table 217: High Throughput Screening (HTS) Market in Australia:Annual Sales Estimates and Forecasts in US$ Million by End-Usefor the Period 2018-2025Table 218: Australian High Throughput Screening (HTS) Market inRetrospect in US$ Million by End-Use: 2009-2017Table 219: High Throughput Screening (HTS) Market ShareDistribution in Australia by End-Use: 2009 VS 2019 VS 2025INDIATable 220: Indian High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type: 2018 to2025Table 221: Indian High Throughput Screening (HTS) HistoricMarket Review by Product Type in US$ Million: 2009-2017Table 222: High Throughput Screening (HTS) Market in India:Percentage Share Breakdown of Sales by Product Type for 2009,2019, and 2025Table 223: High Throughput Screening (HTS) Market Analysis inIndia in US$ Million by Technology: 2018-2025Table 224: High Throughput Screening (HTS) Market in India:Historic Review in US$ Million by Technology for the Period2009-2017Table 225: Indian High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 226: Indian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 227: High Throughput Screening (HTS) Market in India:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 228: Indian High Throughput Screening (HTS) Market ShareAnalysis by Application: 2009 VS 2019 VS 2025Table 229: Indian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by End-Use: 2018 to2025Table 230: High Throughput Screening (HTS) Market in India:Summarization of Historic Demand Patterns in US$ Million byEnd-Use for 2009-2017Table 231: Indian High Throughput Screening (HTS) Market ShareAnalysis by End-Use: 2009 VS 2019 VS 2025SOUTH KOREATable 232: High Throughput Screening (HTS) Market in SouthKorea: Recent Past, Current and Future Analysis in US$ Millionby Product Type for the Period 2018-2025Table 233: South Korean High Throughput Screening (HTS)

Please contact our Customer Support Center to get the complete TabRead the full report: https://www.reportlinker.com/p04368329/?utm_source=PRN

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

Continued here:
Global High Throughput Screening (HTS) Industry | National - Baker City Herald

Stem Cell Concentration System Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2025 – AlgosOnline

The ' Stem Cell Concentration System market' study now available at MarketStudyReport.com, is a detailed sketch of the business sphere in terms of current and future trends driving the profit matrix. The report also indicates a pointwise outline of market share, market size, industry partakers, and regional landscape along with statistics, diagrams, & charts elucidating various noteworthy parameters of the industry landscape.

The research report on the Stem Cell Concentration System market is an in-depth evaluation of this industry space and is inclusive of details pertaining to the growth rate and renumeration attained by the market over the forecast period. The report cites the Stem Cell Concentration System market will amass modest returns by the end of study duration.

Request a sample Report of Stem Cell Concentration System Market at:https://www.marketstudyreport.com/request-a-sample/2594157?utm_source=algosonline.com&utm_medium=sp

Detailed analysis of the Stem Cell Concentration System market sphere is entailed in the report. Thorough insights with respect to projections of industry size, sales pattern, and revenue forecast are depicted. The report further elaborates on important parameters which are slated to drive the market in the upcoming years, alongside the various industry segmentations.

Unveiling the topographical landscape of the Stem Cell Concentration System market:

Ask for Discount on Stem Cell Concentration System Market Report at:https://www.marketstudyreport.com/check-for-discount/2594157?utm_source=algosonline.com&utm_medium=sp

Other takeaways from the Stem Cell Concentration System market report are enlisted below:

For More Details On this Report:https://www.marketstudyreport.com/reports/global-stem-cell-concentration-system-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Some of the Major Highlights of TOC covers:

Stem Cell Concentration System Regional Market Analysis

Stem Cell Concentration System Segment Market Analysis (by Type)

Stem Cell Concentration System Segment Market Analysis (by Application)

Stem Cell Concentration System Major Manufacturers Analysis

Related Reports:

1. Global Saffron Extract Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025This report categorizes the Saffron Extract market data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors Analysis.Read More: https://www.marketstudyreport.com/reports/global-saffron-extract-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

2. Global Bag Valve Masks(BVM) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Bag Valve Masks(BVM) Market report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market.Read More: https://www.marketstudyreport.com/reports/global-bag-valve-masks-bvm-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Related Reports: https://www.marketwatch.com/press-release/automotive-fuel-tank-market-size---industry-analysis-share-growth-trends-top-key-players-and-regional-forecast-2020-2026-2020-04-20

https://www.marketwatch.com/press-release/construction-machinery-market-share---industry-analysis-size-growth-trends-top-key-players-and-regional-forecast-2020-2026-2020-04-20

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

See the rest here:
Stem Cell Concentration System Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2025 - AlgosOnline

Global Stem Cell Media Market 2020: Industry Analysis and Detailed Profiles of Top Key Players Thermo Fisher, STEMCELL Technologies, Merck Millipore,…

Innovate Insights unravels its new study titled Global Stem Cell Media Market Growth, Trends, and Forecast (2017-2023). Effective exploratory techniques such as qualitative and quantitative analysis have been used to discover accurate data.

The Stem Cell Media Market was estimated to be worth USD XXX billion in 2017 and is projected to reach USD XXX billion by the end of 2023, growing at a CAGR of XX% over the forecast period of 2018-2023. The Stem Cell Media industry is highly competitive, due to a large degree of fragmentation in the market. Despite the fragmentation, the market is largely tied by the regulatory requirements for establishment and operation.

The scope of the report is limited to the application of the type, and distribution channel. The regions considered in the scope of the report include North America, Europe, Asia-Pacific, and Rest of the World. This report presents the worldwide Stem Cell Media market size (value, production and consumption), splits the breakdown (data status 20142019 and forecast to 2025), by manufacturers, region, type and application.

We Have Recent Updates of Stem Cell Media Market in Sample Copy: https://www.innovateinsights.com/report/global-stem-cell-media-market-research-report-growth/76119/#requestsample

The major manufacturers covered in this report: Thermo Fisher, STEMCELL Technologies, Merck Millipore, Lonza, GE Healthcare, Miltenyi Biotec, Corning, CellGenix, Takara, PromoCell

The prime objective of this Stem Cell Media research report is to define the size of the different segments and the geographies as well as to forecast the trends that are likely to gain traction in the following couple of years.

Regional Analysis in the Stem Cell Media Market

The biggest demand for Stem Cell Media from North America, Europe, and countries, like China. Asia-Pacific is home to the worlds fastest-growing market for Stem Cell Media, which is reflected in the size of its industry and the rapid rate of expansion in output over recent years. Currently, different companies are aiming to produce Stem Cell Media in many other countries, with current and new areas and projects that are undergoing continuous exploration and feasibility tests.

Stem Cell Media Market Report to grow your business needs and!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted Price@ https://www.innovateinsights.com/report/global-stem-cell-media-market-research-report-growth/76119/#buyinginquiry

Market segment by Type, can be split into: Pluripotent Stem Cell Culture, Hematopoietic Stem Cell Culture, Mesenchymal Stem Cell Culture, Other

Market segment by Application, can be split into: Scientific Research, Industrial Production

The Stem Cell Media report highlights the most recent market trends. Stem Cell Media report unveils vulnerabilities that may emerge because of changes in business activities or presentation of another item in the market. It is designed in such a way that it provides an evident understanding of industry. This Stem Cell Media market report is generated with the combination of best industry insight, practical solutions, talent solutions and latest technology. It explains investigation of the existing scenario of the global market, which takes into account several market dynamics. Stem Cell Media report also perceives the different drivers and limitations affecting the market amid the estimate time frame.

Browse Full Report with Facts and Figures of Stem Cell Media Market Report at: https://www.innovateinsights.com/report/global-stem-cell-media-market-research-report-growth/76119/

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

See more here:
Global Stem Cell Media Market 2020: Industry Analysis and Detailed Profiles of Top Key Players Thermo Fisher, STEMCELL Technologies, Merck Millipore,...

Potential impact of coronavirus outbreak on Canine Stem Cell Therapy Market Size, Top Manufacturers, Product Types, Applications and Specification,…

Analysis Report on Canine Stem Cell Therapy Market

A report on global Canine Stem Cell Therapy market has hit stands. This study is based on different aspects like segments, growth rate, revenue, leading players, regions, and forecast. The overall market is getting bigger at an increased pace due to the invention of the new dynamism, which is making rapid progress.

The given report is an excellent research study specially compiled to provide latest insights into critical aspects of the Global Canine Stem Cell Therapy Market.

Request Sample Report @https://www.mrrse.com/sample/16152?source=atm

Some key points of Canine Stem Cell Therapy Market research report:

Strategic Developments: The custom analysis gives the key strategic developments of the market, comprising R&D, new product launch, growth rate, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Market Features: The report comprises market features, capacity, capacity utilization rate, revenue, price, gross, production, production rate, consumption, import, export, supply, demand, cost, market share, CAGR, and gross margin. In addition, the report offers a comprehensive study of the market dynamics and their latest trends, along with market segments and sub-segments.

Analytical Tools: The Global Canine Stem Cell Therapy Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porters five forces analysis, feasibility study, and many other market research tools have been used to analyze the growth of the key players operating in the market.

COVID-19 Impact on Canine Stem Cell Therapy Market

Adapting to the recent novel COVID-19 pandemic, the impact of the COVID-19 pandemic on the global Canine Stem Cell Therapy market is included in the present report. The influence of the novel coronavirus pandemic on the growth of the Canine Stem Cell Therapy market is analyzed and depicted in the report.

The global Canine Stem Cell Therapy market segment by manufacturers include

Market Taxonomy

The global canine stem cell therapy market has been segmented into:

Product Type:

Application:

End User:

Region:

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/16152?source=atm

Important queries addressed in the report:

Moreover, the report highlighted revenue, sales, manufacturing cost, and product and the States that are most competitive in the lucrative market share idea. There is a discussion on the background and financial trouble in the global Canine Stem Cell Therapy economic market. This included the CAGR value during the outlook period leading to 2025.

Buy This Report @ https://www.mrrse.com/checkout/16152?source=atm

Benefits of Purchasing Canine Stem Cell Therapy Market Report:

Inimitable Expertise: Analysts will provide deep insights into the reports.

Analyst Support: Get your query resolved from our team before and after purchasing the report.

Customers Satisfaction: Our team will assist with all your research needs and customize the report.

Assured Quality: We focus on the quality and accuracy of the report.

Conclusively, this report will provide you a clear view of each and every fact of the market without a need to refer to any other research report or a data source. Our report will provide you with all the facts about the past, present, and future of the concerned Market.

See the original post:
Potential impact of coronavirus outbreak on Canine Stem Cell Therapy Market Size, Top Manufacturers, Product Types, Applications and Specification,...

Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked…

NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang) (MBIO), a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that the European Medicines Agency (EMA) has granted Advanced Therapy Medicinal Product (ATMP) classification to MB-107, Mustangs lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency (XSCID), also known as bubble boy disease. The U.S. Food and Drug Administration (FDA) previously granted Regenerative Medicine Advanced Therapy (RMAT) designation to MB-107 for the treatment of XSCID in August 2019.

EMA grants ATMP classifications to new therapeutics that are based on genes or cells and intended as long-term or permanent therapeutic solutions to acute or chronic human diseases at a genetic, cellular or tissue level. The ATMP program provides specific regulatory guidelines for preclinical development, manufacturing and product quality testing of ATMPs and offers incentives, including fee reductions for regulatory advice, recommendations and evaluation and certification of quality and non-clinical data.

Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, We are extremely encouraged that the EMA has granted MB-107 with ATMP classification, an important step in establishing our path to market approval and commercialization in Europe. This classification complements the RMAT designation we received last year from the FDA and brings us closer to realizing our goal of commercializing MB-107 for XSCID patients, as these patients are in desperate need of innovative and potentially curative treatment options.

MB-107 is currently being assessed in two Phase 1/2 clinical trials for XSCID: the first in newly diagnosed infants under the age of two at St. Jude Childrens Research Hospital (St. Jude), UCSF Benioff Childrens Hospital in San Francisco and Seattle Childrens Hospital and the second in patients over the age of two who have received prior hematopoietic stem cell transplantation at the National Institutes of Health. Under a licensing partnership with St. Jude, Mustang intends to develop the lentiviral gene therapy for commercial use as MB-107.

About Mustang BioMustang Bio, Inc. (Mustang) is a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Mustang aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, to fund research and development, and to outlicense or bring the technologies to market. Mustang has partnered with top medical institutions to advance the development of CAR T therapies across multiple cancers, as well as a lentiviral gene therapy for XSCID. Mustang is registered under the Securities Exchange Act of 1934, as amended, and files periodic reports with the U.S. Securities and Exchange Commission. Mustang was founded by Fortress Biotech, Inc. (FBIO). For more information, visit http://www.mustangbio.com.

ForwardLooking StatementsThis press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on managements current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock value. Factors that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results of research and development activities; risks relating to the timing of starting and completing clinical trials; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Story continues

See more here:
Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked...

Stem Cell Therapy Market 2020 Break Down by Top Companies, Applications, Challenges, Opportunities and Forecast 2026 Cole Reports – Cole of Duty

Allosource

Stem Cell Therapy Market: Competitive Landscape

The last chapter of the Stem Cell Therapy market research report focuses exclusively on the competitive landscape. It examines the main market players. In addition to a brief overview of the business, analysts provide information on their assessment and development. The list of important products in preparation is also mentioned. The competitive landscape is analyzed by understanding the companies strategies and the initiatives they have taken in recent years to overcome intense competition.

Stem Cell Therapy Market: Drivers and Restraints

The report explains the drivers of the future of the Stem Cell Therapy market. It assesses the different forces which should have a positive impact on the whole market. Analysts have looked at investments in research and development for products and technologies, which should give players a significant boost. In addition, the researchers undertook an analysis of the evolution of consumer behavior which should have an impact on the cycles of supply and demand in the Stem Cell Therapy market. In this research report, changes in per capita income, improvement in the economic situation and emerging trends were examined.

The research report also explains the potential restrictions on the Stem Cell Therapy market. The aspects assessed are likely to hamper market growth in the near future. In addition to this assessment, it offers a list of opportunities that could prove lucrative for the entire market. Analysts offer solutions to turn threats and restrictions into successful opportunities in the years to come.

Stem Cell Therapy Market: Regional Segmentation

In the following chapters, analysts have examined the regional segments of the Stem Cell Therapy market. This gives readers a deeper insight into the global market and allows for a closer look at the elements that could determine its evolution. Countless regional aspects, such as the effects of culture, environment and government policies, which affect regional markets are highlighted.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24113&utm_source=COD&utm_medium=007

What will the report contain?

Market Dynamics: The report contains important information on influencing factors, market drivers, challenges, opportunities and market trends as part of the market dynamics.

Global Market Forecast: Readers receive production and sales forecasts for the Stem Cell Therapy market, production and consumption forecasts for regional markets, production, sales and price forecasts for the Stem Cell Therapy market by type and consumption forecasts for the Stem Cell Therapy market per application.

Regional Market Analysis: It can be divided into two different sections: one for the analysis of regional production and one for the analysis of regional consumption. Here, analysts share gross margin, prices, sales, production, CAGR, and other factors that indicate the growth of all regional markets examined in the report.

Market Competition: In this section, the report provides information on the situation and trends of competition, including mergers and acquisitions and expansion, the market shares of the three or five main players and the concentration of the market. Readers could also get the production, revenue, and average price shares of manufacturers.

Key Players: The report provides company profiles for a decent number of leading players in the Stem Cell Therapy market. It shows your current and future market growth taking into account price, gross margin, income, production, service areas, production locations and other factors.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Therapy-Market/?utm_source=COD&utm_medium=007

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.

2- Free Competitive analysis of any market players.

3- Free 40 analyst hours to cover any other data points

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes, Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Get Our Trending Report

Rich Mineral Paper Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Tags: Stem Cell Therapy Market Size, Stem Cell Therapy Market Trends, Stem Cell Therapy Market Forecast, Stem Cell Therapy Market Growth, Stem Cell Therapy Market Analysis

Read the original post:
Stem Cell Therapy Market 2020 Break Down by Top Companies, Applications, Challenges, Opportunities and Forecast 2026 Cole Reports - Cole of Duty

Coronavirus focus tipped to ‘mothball’ biotech research – The Age

Chief executive of contract research operator Novotech, Dr John Moller, said many research sites across the Asia-Pacific region were modifying operations to keep running projects remotely.

"Some sites are reconfiguring their operations to work in the new environment they may be undertaking increased levels of remote monitoring or they may move their clinical trial sites away from areas where they are likely to treat COVID patients," he said.

"A majority of sites continue to be very interested in new studies and the review and approval of non-COVID-19 clinical trials are continuing."

Despite this, company founders said the sector was facing many unknowns.

Chief executive of stem cell therapies company Cynata Therapeutics, Ross MacDonald, said recruitment for upcoming planned research was on hold as the business waited on answers.

"We don't know. We're in the same situation as everyone else at the moment, and looking to the government to ask, 'when are we getting out of this?'" he said.

Cynata's research blueprint for this year includes a phase two clinical trial of its product for treatment of osteoarthritis and critical limb ischemia, an artery disease.

Ms Chiroiu said after the pandemic was over she believed the move to remote healthcare services would be a "lasting legacy" that would enable companies to include a wider variety of Australians in research.

A move to virtual consultations could actually change how Australians recruit and monitor research patients, she said, a move policy experts have agreed would be a major win for more inclusive medical research.

Loading

"There has been lots of talk at policy level about involving more rural and remote communities in clinical trials. There's a move towards trying to conduct telehealth consults wherever possible it will be a great jump start to that," she said.

However, companies that do not have strong capital bases may not live long enough to see that change, she warned.

"Those wanting to raise money will have to wait until the other side ... and there is still investment capital around, but just much less that there was."

Follow MySmallBusiness on Twitter, Facebook and LinkedIn.

Get our Coronavirus Update newsletter for the day's crucial developments at a glance, the numbers you need to know and what our readers are saying. Sign up to The Sydney Morning Herald's newsletter here and The Age's here.

Emma is the small business reporter for The Age and Sydney Morning Herald based in Melbourne.

Read the rest here:
Coronavirus focus tipped to 'mothball' biotech research - The Age

Resilience Hope and Being a Survivor – Curetoday.com

When I first heard the word "resilience" I did not really understand what it meant, I was listening to a presentation about a third world mission trip and about how people survive their hardships there. But now, I personally understand the meaning and am ready to share my journey.

When my husband was diagnosed with cancer, I understood what may be ahead, since I am a nurse with many years of experience. The first two years of his journey were stressful, but we had each other, enjoyed our life and worked through the decisions and experience. The turning point was when he his cancer returned, and he started radiation therapy. Then, we hit what felt like a big wall.

I was diagnosed with breast cancer.

I remember sharing this news with him and he stated, "I am stronger than you think" and he proved that to be so true over the next 3 years.

Our journey together is a story of resilience, sharing hope and caring for each other. His cancer involved traveling over 3 hours to a medical center for surgery, needing an artificial airway and nutrition via a feeding tube. We spent our time together going to the local cancer center on separate days for each of our own chemotherapy treatments. As a nurse, I cared for him even during my own radiation treatment period and still kept working at my job as much as possible.

During that time, I kept thinking, is this what it takes to have that resilience? Is resilience what it takes to keep caring, maintaining hope and surviving a day at a time. If you look up the word, " resilience", there are terms like hardiness, strength and toughness. However, I have learned that it means much more.

The experience of a cancer journey together is more than what those words convey. I would often say to myself, " I am stronger than I thought too" not realizing I was beginning to understand resilience. When looking inward, you begin to understand the human spirit and what we face in life cannot truly be explained to others, but only matures every day with every hurdle we tackle and overcome.

I am a widow now and a cancer survivor, who looks back on that time in our lives, with joy of being together, with pride at how we both endured and how much stronger we became because of it. Hope was always in front of us, leading us through each day.

You should never lose hope, because that optimism is what builds the courage that leads to learning what resilience really means.

Follow this link:
Resilience Hope and Being a Survivor - Curetoday.com

What are the underlying conditions causing more serious illness from coronavirus? – KSBW The Central Coast

We've heard that elderly people and those with underlying health conditions are most at risk if they're infected with coronavirus, but those can seem like really general terms. Who does that include? And why can they face more serious illness?"According to the , some of the underlying conditions that may put you at higher risk include: chronic lung disease and asthma, heart disease and undergoing cancer treatment," said CNN Chief Medical Correspondent Dr. Sanjay Gupta. Anyone with diabetes, kidney failure or liver failure may also be at higher risk.The role of the immune system is to protect against disease or other potentially damaging pathogens. A strong one is needed to help stave off coronavirus infection."Think of it like this," Dr. Gupta suggested. "In your everyday life, you're always fighting off pathogens. Most of the time you don't even realize it. If you have an underlying condition, it makes it more challenging to fight off a virus like this. You may develop a fever, shortness of breath or a cough more easily than someone who doesn't have a preexisting illness."Additionally, there are more specific reasons why each condition has its own vulnerabilities. Here's a guide to underlying conditions affected by coronavirus and why, and how you can protect yourself or an at-risk loved one.Older adultsEight out of 10 deaths reported in the U.S. have been in adults ages 65 and older, according to the CDC. Older adults have also been more likely to require hospitalization and admission to an intensive care unit.Older adults are more likely to have long-term health problems that can increase their risk for infection and serious disease. And, our immune systems usually weaken with age, making it more difficult for people to fight off infections, according to Johns Hopkins Medicine.The quality of our lung tissue also declines over time, becoming more elastic and making respiratory diseases such as COVID-19 of important concern because of the potential for lung damage.Inflammation in older adults can be more intense, leading to organ damage.Those with lung disease, asthma or heart conditionsPeople with chronic airway and lung diseases such as chronic obstructive pulmonary disease, asthma, pulmonary fibrosis and interstitial lung disease can lay the foundations for more severe infection with coronavirus because of the inflammation, scarring and lung damage those conditions cause, Johns Hopkins Medicine reported.COVID-19 affects a person's airway and lungs, but those organs work together to provide the body with oxygen. When the lungs are overburdened with an infection, the heart has to work harder, which exacerbates the challenges of people already living with heart disease.The immunocompromisedAccording to the CDC, many conditions can cause a person to be immunocompromised, including cancer treatment, smoking, bone marrow or organ transplantation and immune deficiencies. Poorly controlled HIV or AIDS and prolonged use of man-made steroid hormones or other immune-weakening medications can also hamper a person's immune function.Cancer can weaken immunity by spreading into the bone marrow, which makes blood cells that help fight infection, according to Cancer Research UK. Cancer prevents bone marrow from making enough blood cells.Some cancer treatments can temporarily weaken the immune system, too. Because cancer treatments such as chemotherapy, cancer drugs, radiotherapy or steroids are targeted toward cancer cells, they can also diminish the number of white blood cells created in the bone marrow.A 2017 study found cigarette smoking can harm the immune system by either causing extreme immune responses to pathogens or rendering the body less effective at fighting disease. This may occur by smoking, negatively altering the cellular and molecular mechanisms responsible for keeping an immune system strong.When a person undergoes a bone marrow transplant using stem cells from a donor, or they receive an organ, a doctor may prescribe medications to prevent graft-versus-host disease and mitigate the immune system's reaction by suppressing its function. After the operation, it takes time for your immune system to be up and running again.HIV and AIDS attack the body's immune system, specifically the body's T cells, which help the immune system fight off infection. When the diseases are untreated, HIV reduces the number of those cells, making the person more likely to contract other infections or infection-related cancer, according to the CDC.Severe obesityPeople with severe obesity, or a body mass index of 40 or higher, are at higher risk of serious disease."Obesity shares with most chronic diseases the presence of an inflammatory component," a 2012 study said. Inflammatory responses were linked between the immune system and body fat. Obesity is known to impair immune function by altering white blood cell count as well as the cells that control immune responses.DiabetesPeople with type 1 or type 2 diabetes face an increased risk of getting really sick with COVID-19, as both cause a blood sugar spike. If blood sugar is poorly managed, viral diseases can be more dangerous as high blood sugar may give viruses a place to thrive, according to Diabetes in Control, a news and information resource for medical professionals.Higher levels of inflammation have been discovered in the bodies of people with diabetes, weakening the immune system and making it more difficult for those affected to stave off sickness in general.Kidney and liver diseaseThe kidneys produce several hormones that affect immune responses. Having kidney disease and failure can weaken your immune system, making it easier for infections to take hold. According to the National Kidney Foundation, doctors and researchers have found that most infections are worse in people with kidney disease.The liver is an integral member of the body's line of defense, helping to regulate the number of white blood cells utilized in immune responses and defend against harmful pathogens. Someone with liver disease is experiencing abnormalities in the function of the immune system, giving rise to more serious illness.Neurodevelopmental conditionsNeurological and neurodevelopmental conditions may also increase the risk of serious COVID-19 for people of any age.These include disorders of the brain, spinal cord, peripheral nerve and muscle such as cerebral palsy, epilepsy, stroke and intellectual disability, according to the CDC. Those with moderate to severe developmental delay, muscular dystrophy or spinal cord injury are also more at-risk.People with neurological conditions may not be more at risk due to solely their condition, but because medications they might take to control their condition could hamper their immune system. However, some neurological conditions, such as Parkinson's, have been recognized to have inflammatory components, which may harm the immune system.Others including muscular dystrophy, multiple sclerosis or amyotrophic lateral sclerosis (ALS) could cause paralysis to the diaphragm, which leaves those affected very at risk for respiratory failure if they were to be sick with COVID-19.Staying safe when you're more at riskIf you see yourself on the list of those at higher risk for severe illness, there are several things you can do to protect yourself. First, make sure you are contact your doctor or doctors about your risk level. Second, be extra vigilant about the recommendations that most people are being asked to follow.Stay home whenever possible and avoid close contact with people, the CDC suggests. Wash your hands often to prevent transferring the virus from a surface to your face, and try to clean and disinfect frequently touched surfaces as often as you can.If you don't have an underlying condition, doing your part by practicing these cautionary measures can help protect not only you, but your loved ones with existing conditions.

We've heard that elderly people and those with underlying health conditions are most at risk if they're infected with coronavirus, but those can seem like really general terms. Who does that include? And why can they face more serious illness?

"According to the [Centers for Disease Control and Prevention], some of the underlying conditions that may put you at higher risk include: chronic lung disease and asthma, heart disease and undergoing cancer treatment," said CNN Chief Medical Correspondent Dr. Sanjay Gupta. Anyone with diabetes, kidney failure or liver failure may also be at higher risk.

The role of the immune system is to protect against disease or other potentially damaging pathogens. A strong one is needed to help stave off coronavirus infection.

"Think of it like this," Dr. Gupta suggested. "In your everyday life, you're always fighting off pathogens. Most of the time you don't even realize it. If you have an underlying condition, it makes it more challenging to fight off a virus like this. You may develop a fever, shortness of breath or a cough more easily than someone who doesn't have a preexisting illness."

Additionally, there are more specific reasons why each condition has its own vulnerabilities. Here's a guide to underlying conditions affected by coronavirus and why, and how you can protect yourself or an at-risk loved one.

Eight out of 10 deaths reported in the U.S. have been in adults ages 65 and older, according to the CDC. Older adults have also been more likely to require hospitalization and admission to an intensive care unit.

Older adults are more likely to have long-term health problems that can increase their risk for infection and serious disease. And, our immune systems usually weaken with age, making it more difficult for people to fight off infections, according to Johns Hopkins Medicine.

The quality of our lung tissue also declines over time, becoming more elastic and making respiratory diseases such as COVID-19 of important concern because of the potential for lung damage.

Inflammation in older adults can be more intense, leading to organ damage.

People with chronic airway and lung diseases such as chronic obstructive pulmonary disease, asthma, pulmonary fibrosis and interstitial lung disease can lay the foundations for more severe infection with coronavirus because of the inflammation, scarring and lung damage those conditions cause, Johns Hopkins Medicine reported.

COVID-19 affects a person's airway and lungs, but those organs work together to provide the body with oxygen. When the lungs are overburdened with an infection, the heart has to work harder, which exacerbates the challenges of people already living with heart disease.

According to the CDC, many conditions can cause a person to be immunocompromised, including cancer treatment, smoking, bone marrow or organ transplantation and immune deficiencies. Poorly controlled HIV or AIDS and prolonged use of man-made steroid hormones or other immune-weakening medications can also hamper a person's immune function.

Cancer can weaken immunity by spreading into the bone marrow, which makes blood cells that help fight infection, according to Cancer Research UK. Cancer prevents bone marrow from making enough blood cells.

Some cancer treatments can temporarily weaken the immune system, too. Because cancer treatments such as chemotherapy, cancer drugs, radiotherapy or steroids are targeted toward cancer cells, they can also diminish the number of white blood cells created in the bone marrow.

A 2017 study found cigarette smoking can harm the immune system by either causing extreme immune responses to pathogens or rendering the body less effective at fighting disease. This may occur by smoking, negatively altering the cellular and molecular mechanisms responsible for keeping an immune system strong.

When a person undergoes a bone marrow transplant using stem cells from a donor, or they receive an organ, a doctor may prescribe medications to prevent graft-versus-host disease and mitigate the immune system's reaction by suppressing its function. After the operation, it takes time for your immune system to be up and running again.

HIV and AIDS attack the body's immune system, specifically the body's T cells, which help the immune system fight off infection. When the diseases are untreated, HIV reduces the number of those cells, making the person more likely to contract other infections or infection-related cancer, according to the CDC.

People with severe obesity, or a body mass index of 40 or higher, are at higher risk of serious disease.

"Obesity shares with most chronic diseases the presence of an inflammatory component," a 2012 study said. Inflammatory responses were linked between the immune system and body fat. Obesity is known to impair immune function by altering white blood cell count as well as the cells that control immune responses.

People with type 1 or type 2 diabetes face an increased risk of getting really sick with COVID-19, as both cause a blood sugar spike. If blood sugar is poorly managed, viral diseases can be more dangerous as high blood sugar may give viruses a place to thrive, according to Diabetes in Control, a news and information resource for medical professionals.

Higher levels of inflammation have been discovered in the bodies of people with diabetes, weakening the immune system and making it more difficult for those affected to stave off sickness in general.

The kidneys produce several hormones that affect immune responses. Having kidney disease and failure can weaken your immune system, making it easier for infections to take hold. According to the National Kidney Foundation, doctors and researchers have found that most infections are worse in people with kidney disease.

The liver is an integral member of the body's line of defense, helping to regulate the number of white blood cells utilized in immune responses and defend against harmful pathogens. Someone with liver disease is experiencing abnormalities in the function of the immune system, giving rise to more serious illness.

Neurological and neurodevelopmental conditions may also increase the risk of serious COVID-19 for people of any age.

These include disorders of the brain, spinal cord, peripheral nerve and muscle such as cerebral palsy, epilepsy, stroke and intellectual disability, according to the CDC. Those with moderate to severe developmental delay, muscular dystrophy or spinal cord injury are also more at-risk.

People with neurological conditions may not be more at risk due to solely their condition, but because medications they might take to control their condition could hamper their immune system. However, some neurological conditions, such as Parkinson's, have been recognized to have inflammatory components, which may harm the immune system.

Others including muscular dystrophy, multiple sclerosis or amyotrophic lateral sclerosis (ALS) could cause paralysis to the diaphragm, which leaves those affected very at risk for respiratory failure if they were to be sick with COVID-19.

If you see yourself on the list of those at higher risk for severe illness, there are several things you can do to protect yourself. First, make sure you are contact your doctor or doctors about your risk level. Second, be extra vigilant about the recommendations that most people are being asked to follow.

Stay home whenever possible and avoid close contact with people, the CDC suggests. Wash your hands often to prevent transferring the virus from a surface to your face, and try to clean and disinfect frequently touched surfaces as often as you can.

If you don't have an underlying condition, doing your part by practicing these cautionary measures can help protect not only you, but your loved ones with existing conditions.

See the original post here:
What are the underlying conditions causing more serious illness from coronavirus? - KSBW The Central Coast